What are the Current Recommendations for Metastatic Hormone-Sensitive Prostate Cancer in 2019?

In this downloadable slideset, Daniel W. Lin, MD, reviews the latest evidence and guidelines supporting the optimal management of patients with metastatic hormone-sensitive prostate cancer.
Daniel W. Lin, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.14 MB
Released: May 3, 2019


Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0283 (Fax)
For Clinicians:
For Patients:

Supported by independent educational grants from
Pfizer Inc.

Related Content

From ASCO 2020: analysis by Daniel P. Petrylak, MD, and Elizabeth R. Plimack, MD, MS, of key studies in renal cell carcinoma, urothelial carcinoma, and prostate cancer from CCO

Daniel P. Petrylak, MD Elizabeth R. Plimack, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: September 1, 2020 Expired: August 31, 2021

From Clinical Care Options (CCO), an on-demand Webcast on immuno-oncology biomarkers that are key to optimal cancer treatment across multiple tumors

John L. Marshall, MD
Program Director
Jamie E. Chaft, MD Scot Niglio, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 24, 2020 Expired: August 23, 2021

From Clinical Care Options (CCO), watch video of an expert discussion of NTRK fusion testing and TRK inhibitor use in solid cancers

George D. Demetri, MD
Program Director
person default Alexander Drilon, MD Pashtoon Kasi, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 21, 2020 Expired: August 20, 2021

From Clinical Care Options (CCO), video featuring expert presentations on the role of PARP inhibition in the treatment of prostate cancer

Celestia Higano Headshot Celestia S. Higano, MD, FACP
Program Director
Charles J. Ryan, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 10, 2020 Expired: August 9, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?